Fibrinogen synthesis in the intact rat was perturbed by treatment with cycloheximide. Specific radioactivities of fibrinogen in plasma and liver both decreased at 2h after treatment and increased over 2-fold by 18 h. Labelled-antibody-polyribosome binding experiments showed that more polyribosomes were engaged in fibrinogen synthesis at 18 h after treatment. Radioactivity of plasma fibrinogen chains from untreated control rats showed a constant ratio of Aa-B16/y = 1.03. At 2 h after cycloheximide treatment the Aa-and Bf,-chains showed the greatest decrease in labelling (Aa-Bfi/y = 0.66) and at 18 h all chains were much more labelled (the Aa-Bfl/y ratio changed to 1.39). The observed imbalance in fibrinogen-chain synthesis suggests that cycloheximide has a selective effect on gene expression.
Philadelphia, PA 19102, U.S.A. (Received 20 November 1978)
Fibrinogen synthesis in the intact rat was perturbed by treatment with cycloheximide. Specific radioactivities of fibrinogen in plasma and liver both decreased at 2h after treatment and increased over 2-fold by 18 h. Labelled-antibody-polyribosome binding experiments showed that more polyribosomes were engaged in fibrinogen synthesis at 18 h after treatment. Radioactivity of plasma fibrinogen chains from untreated control rats showed a constant ratio of Aa-B16/y = 1.03. At 2 h after cycloheximide treatment the Aa-and Bf,-chains showed the greatest decrease in labelling (Aa-Bfi/y = 0.66) and at 18 h all chains were much more labelled (the Aa-Bfl/y ratio changed to 1.39). The observed imbalance in fibrinogen-chain synthesis suggests that cycloheximide has a selective effect on gene expression.
The rate of synthesis and plasma concentrations of fibrinogen change in response to many conditions causing tissue damage and inflammation (Koj, 1970) , such as treatment with turpentine (Weimer & Humelbaugh, 1967; Kwan & Fuller, 1977) or pyrogen (Bocci et al., 1976) . We have reported that a single injection of a non-lethal dose of cycloheximide into rats alters the rate of plasma fibrinogen synthesis. Synthesis was drastically inhibited at 2h, but at 12 and 18 h after the antibiotic administration there was a 3-fold stimulation (Ch'ih et al., 1977a) . This biphasic phenomenon led us to investigate the possible molecular mechanism of fibrinogen biosynthesis in the intact rat using cycloheximide as a perturbing agent. A preliminary report on part of this work has been presented (Procyk et al., 1978) .
Experimental
The experiments were performed on male Wistar rats (210+± 0g). Maintenance of the animals, treatment with cycloheximide, collection of plasma and removal of livers were carried out as described by Ch'ih et al. (1977a) . Plasma fibrinogen was purified by the method of and analysed by acid/urea/polyacrylamide-gel electrophoresis (Brummel & Montgomery, 1970) . Fibrinogen chains were reduced, alkylated and separated by CMcellulose chromatography (McDonagh et al., 1972) . Anti-(rat fibrinogen) antibodies were purified from rabbit antisera by affinity chromatography on columns of fibrinogen-Sepharose . Iodination was carried out with BoltonHunter Reagent (Amersham, Arlington Heights, IL, U.S.A.). Isolation of liver cytoplasmic ribonucleoprotein complexes and polyribosome separation were performed as described by Ch'ih et al. (1977b) . Supernatants of the fractions from which ribonucleoprotein complexes were isolated were titrated with anti-fibrinogen, and, at the equivalence point, precipitated antibody-fibrinogen complexes were collected by centrifugation (5000g for 10min). Radioactivity was determined as described by Devlin & Ch'ih (1974) . Protein was measured by the method of Lowry et al. (1951) , with bovine serum albumin as standard.
Results and Discussion
In the first phase of this investigation, experiments were performed to assess the effect of cycloheximide on fibrinogen synthesis. The goal of these initial studies was not to measure the rate of synthesis, as this has been determined previously (Ch'ih et al., 1977a) . Rather, the goal was to develop a consistent picture of liver fibrinogen synthesis when this process was perturbed by cycloheximide. Table 1 presents specific radioactivities of fibrinogen in plasma and liver. Both sets of data show decreased fibrinogen synthesis at 2h and stimulation at 18h after cycloheximide treatment. The purified plasma fibrinogen values were lower than those obtained earlier by thrombin precipitation (Ch'ih et al., 1977a) ; however, this is presumably a reflection of fibrinogen accumulation in the plasma. The 2.3-fold stimulation of fibrinogen labelling observed here at 18 h after cycloheximide administration, when corrected by 18% for accumulation (Ch'ih et al., 1976) , rises to 2.8-fold, a value in agreement with the earlier data. Interestingly, the relative ratio of fibrinogen specific radioactivity in plasma to that in The binding of 'l25-labelled anti-fibrinogen to liver polyribosomes was used to identify the region of a polyribosomal profile that was engaged in fibrinogen synthesis . This type of experiment was conducted to determine the effect of cycloheximide on antibody-polyribosomal binding. Labelled antibody was incubated with polyribosomes from untreated and cycloheximide-treated animals (Fig.  1) . In all cases a significant peak of radioactivity appeared in the heavy-polyribosomal region. The material in this peak was sensitive to ribonuclease and unaffected by subsequent additions of fibrinogen and anti-fibrinogen to the reaction mixture (results not shown). Greater amounts of antibody were bound to polyribosomes from animals 18 h after treatment with cycloheximide than to control polyribosomes (about 133 % of control). At 2h after treatment, less labelled antibody was bound (66 % of control). This implies that during the period of stimulated protein synthesis there were more polyribosomes engaged in fibrinogen synthesis, and therefore the rate of label incorporation increased. The opposite would be true for the circumstances after 2h.
Although substantial changes in the rate of fibrinogen synthesis after cycloheximide treatment have been demonstrated, some technical problems complicated our attempts to assess qualitative differences in the antibody-polyribosomal binding for the treated conditions. Some antibody bound to the light-polyribosomal region in samples from 18h-treatedanimals; however, the significance ofthis binding is not yet understood. Sincefibrinogen is composed of three different polypeptide chains (Blomback & Yamashina, 1958) selected regions on the CM-cellulose-elution profile of reduced alkylated rat plasma fibrinogen (Fig. 2) . The presence of y-chain in the first peak and Aax-BIJchains in the second peak was demonstrated by polyacrylamide-gel electrophoresis (results not shown). The ratio of specific radioactivities of the peak fractions from the Aa-and Bfi-chain region to the y-chain region was close to unity for fibrinogen purified from untreated rats ( Table 2 ). With two different [3H]leucine dosages for control animals, the specific radioactivities increased proportionally in both fractions with the ratio remaining constant, indicating that leucine incorporation into the fibrinogen chains is dependent on the amount of label administered and the ratio is independent of the amount. The ratios of 1.02 and 1.04 obtained for the untreated animals approach the calculated ratio determined by dividing each peak area in Fig. 2 by the leucine composition of the fibrinogen chains in , A280; , concentration of sodium acetate (mM).
that peak Van RuijvenVermeer & Nieuwenhuizen, 1978) . The ratio of the calculated value of Aa-and Bf6-chain to y-chain leucine content is about 0.92; our experimentally determined value was 1.02-1.04.
As shown in Table 2 , fibrinogen-chain synthesis after cycloheximide administration was first inhibited and then stimulated, a response similar to that exhibited by the intact molecule (Table 1) Vol. 178
